Why this cannabis company's shares rocketed 39% higher today

The Althea Group Holdings Ltd (ASX:AGH) share price has been a huge mover on the ASX on Friday. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performers on the Australian share market on Friday has been the Althea Group Holdings Ltd (ASX: AGH) share price.

The cannabis company's shares were up as much as 39% to 52.5 cents at one stage. Its shares have since given back a good portion of these gains, but still sit higher by 15.5% at 44.5 cents.

Why did Althea's shares rocket higher today?

This morning Althea announced that it has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.

According to the release, the licence provides Althea with authorisation to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits.

Althea's CEO Josh Fegan appeared to be delighted with the news.

He said: "Althea is excited at receiving our Manufacture Licence. Coupled with the existing Medicinal Cannabis Licence, Althea can now proceed with the next phase of planning for our Victorian based production facility. Althea shareholders can look forward to a vertically integrated, seed-to-sale, state of the art medicinal cannabis operation, comparable to that of our Canadian partner Aphria,"

As of yesterday's close, Aphria was valued at a sizeable C$3.8 billion, making it one of the biggest cannabis companies in the world.

In addition to this, Mr Fegan updated the market on the company's patient approvals and prescribing doctors

He advised that: "Patients approved for Althea medicinal cannabis products have quickly surpassed the recent 100 patient milestone, with 127 patients now approved."

There has been similarly solid growth in the number of doctors prescribing its products. These have increased from 42 to 50 during the last couple of weeks.

It is, however, still a long way off its target of 1,000 patient by this time next year. Though, it believes the "comprehensive work we are doing educating mainstream doctors across Australia, makes that a distinct possibility."

Should you invest?

I like what I've seen with Althea since its listing and believe it is up there with Auscann Group Holdings Ltd (ASX: AC8) and Cann Group Ltd (ASX: CAN) as having the best chance to succeed in the fiercely competitive domestic market.

However, whether or not medicinal cannabis actually takes off in Australia, only time will tell.

Because of this and the reasonable amount of success already being baked into their shares, I would suggest investors restrict these cannabis companies to just their watchlists for the time being.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »